PoltregS.A.Status: Entity active
Manufacture of pharmaceutical preparations
KRS: 0000637215 NIP: 9571079577 REGON: 36194531800000
Overview
Registry date
2016-09-15
Share capital
$159,817.83
Activity description
Poltreg is a company that specializes in Treg autoimmune therapy, focusing on developing cell therapies for autoimmune diseases. It has a pipeline that includes PTG007, a potential treatment for Type-1 Diabetes and Multiple Sclerosis, and is working on launching in-patient trials for CAR-Tregs in Multiple Sclerosis and Amyotrophic Lateral Sclerosis. The company also boasts world-class manufacturing capabilities and aims to bring Treg therapies to routine use as disease-modifying therapeutics.
Registered address
Ul. Botaniczna 20, 80-298 Gdańsk, Poland
Website
poltreg.comWebsite active
Industry
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o. | $1,592,037.83 | sulphur.com.pl | |
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,578,016.20 | labor.com.pl | |
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $979,280.96 | lekinatury.pl | |
| Human BiomeS.A. | $888,361.19 | human-biome.com | |
| Biomarsp. z o.o. | $877,113.96 | biomar.pl | |
| DR Andresp. z o.o. | $313,167.24 | drandre.pl | |
| BLAU Farma GroupS.K.A. | $184,427.88 | blaufarma.pl | |
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com/ | |
| Ampliconsp. z o.o. | $147,800.80 | amplicon.pl | |
| Zeptor Polskasp. z o.o. | $137,700.88 | zeptor.pl |
Change history
| Event | Details | Date | |
|---|---|---|---|
| Share capital change | 466344.80 PLN → 591645.60 PLN | 2026-04-16 |
Last updated: 2026-04-28